StateFederal Regulatory Clash Escalates Over Prediction Markets 16 States Pursue Legal Action
Suzlon Energy Reports Strong Q4 Revenue Growth Eyes Renewable Expansion
Samsung Chip Workers Poised for Record Bonuses as AI Demand Drives Semiconductor Profits
Pinterest Faces Analyst Scrutiny Amid Evolving Digital Advertising Landscape
Walmart Kroger and ELF Beauty Announce Price Cuts Potential Margin Pressures Ahead
EOG Resources Soared in Q1 Oil Price Rally and Operational Strength Drive Gains
NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20
FUNC Q1 2026 Earnings EPS Surpasses Estimates by 87 Amid Solid Operating Performance
Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations
SPOK Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Slips
Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss Weighs on Sentiment
EGO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
MFAO Holds Steady Near 2520 as Senior Notes Trade in Tight Range
Gain Therapeutics GANX Surges 147 as Volume Picks Up Testing Resistance at 213
MIND CTI MNDO Bounces 326 Nearing Key Resistance at 10
Invesco Municipal Trust VKQ Edges Higher as Bond Market Stabilizes
Essential Utilities WTRG Edges Higher Amid Defensive Positioning
UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Leisure A Surprise CostofLiving Measure
PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines
Praetorian Acquisition Corp PTOR Holds Steady Near Support Amid Muted Activity
Planet Green Holdings PLAG Holds Steady at 163 as Tight Trading Range Persists
Murano Global Investments MRNO Bounces from 030 Support Key Levels to Watch
GRAIL Inc GRAL Surges 56 as Momentum Builds Toward Key Resistance
Franklin Resources BEN Holds Steady Near Key Support as Asset Manager Faces Headwinds
PureCycle Technologies Unit PCTTU Holds Steady at 620 as Traders Eye Key Support and Resistance Levels
Pelican Acquisition PELI Shares Tumble 1179 Support Levels in Focus
Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes